What is Colorectal Cancer?
Colorectal cancer begins in the colon or rectum, usually developing from a precancerous polyp over several years. That slow progression is why screening works so well — removing polyps prevents cancer entirely. US guidance recommends screening begin at age 45 for people at average risk, using colonoscopy or one of several stool-based or imaging alternatives.
Key takeaways
- Screening at average risk now starts at 45 in the US, lowered from 50 because of rising incidence in younger adults.
- Most colorectal cancers develop from polyps over 10-15 years, so screening can prevent cancer, not just detect it.
- Several screening options exist; the best test is the one you will actually complete on schedule.
- Any rectal bleeding or persistent change in bowel habit deserves evaluation regardless of age.
- Survival is high when the cancer is found early and confined to the bowel wall.
Overview
Colorectal cancer is one of the most common cancers worldwide and one of the few that can be largely prevented rather than merely detected early. Most cases begin as an adenomatous polyp, a small growth on the inner lining of the colon or rectum that is initially harmless. Over roughly ten to fifteen years, some polyps accumulate genetic changes and become cancerous. Because that window is so long, finding and removing polyps during screening stops the process before cancer ever develops.
The demographics have been shifting. Incidence in adults under 50 has been rising for several decades, which led US guidelines to lower the recommended screening start age to 45. At the same time, overall incidence in older adults has fallen, largely because of screening uptake. Symptoms in early disease are often absent, so relying on how you feel is not a substitute for testing.
What Colorectal Cancer is
Colorectal cancer arises from the epithelial lining of the large bowel. The conventional adenoma-carcinoma sequence involves progressive mutations in genes such as APC, KRAS, and TP53; a second pathway involves serrated polyps. Roughly two-thirds occur in the colon and one-third in the rectum, and the location influences both symptoms and treatment.
Staging describes how deeply the tumour has invaded the bowel wall, whether lymph nodes are involved, and whether it has spread to other organs — most commonly the liver and lungs. Stage drives prognosis and treatment far more than tumour size does. About 5% of cases are linked to inherited syndromes such as Lynch syndrome or familial adenomatous polyposis, which require earlier and more frequent surveillance and family testing.
Common symptoms
Early colorectal cancer often causes no symptoms, which is the central argument for screening.
- No symptoms at all in early disease
- Rectal bleeding or blood in the stool — bright red or dark
- A persistent change in bowel habit lasting more than a few weeks
- Stools that are narrower than usual
- A feeling that the bowel does not empty completely
- Persistent abdominal discomfort, cramping, or bloating
- Unexplained fatigue or weakness, often from iron deficiency anemia
Less common symptoms
- Unintentional weight loss
- Iron deficiency anemia in a man or postmenopausal woman with no obvious cause — always warrants investigation
- Nausea and vomiting from partial bowel obstruction
- A palpable abdominal mass
- Sudden complete obstruction or bowel perforation as the first presentation
Risk factors
- Age 45 and older — risk rises with age, though younger cases are increasing
- Personal history of colorectal polyps or cancer — the strongest individual risk marker
- Family history of colorectal cancer or advanced polyps, particularly in a first-degree relative under 60
- Inherited syndromes such as Lynch syndrome or familial adenomatous polyposis — a small share of cases but very high individual risk
- Inflammatory bowel disease — ulcerative colitis or Crohn colitis of long duration
- Obesity and physical inactivity — both consistently associated with higher risk
- Diets high in red and processed meat and low in fibre
- Smoking and heavy alcohol use — both raise risk in a dose-related way
- Type 2 diabetes — associated independently of weight
Causes
Colorectal cancer develops through the accumulation of genetic and epigenetic changes in cells lining the bowel. Most of these changes are acquired over a lifetime rather than inherited, driven by a combination of chance replication errors and exposures — including dietary factors, chronic inflammation, tobacco, and alcohol. The gut microbiome is an active area of research as a contributing influence.
Inherited syndromes account for roughly 5% of cases. Lynch syndrome, caused by defects in DNA mismatch repair genes, is the most common and also raises the risk of endometrial and other cancers. Identifying it changes surveillance intervals and prompts testing of relatives, which is why family history should be reviewed carefully.
How it is diagnosed
Screening tests look for cancer or polyps before symptoms appear; diagnostic testing follows an abnormal screen or concerning symptoms.
| Test or assessment | What it looks at |
|---|---|
| Colonoscopy | Direct examination of the entire colon and rectum, allowing polyps to be removed during the same procedure. Typically repeated every 10 years at average risk if normal. |
| Fecal immunochemical test (FIT) | A stool test detecting hidden blood, done annually at home. A positive result must be followed by colonoscopy to be meaningful. |
| Multi-target stool DNA test | Combines blood detection with DNA markers, generally done every three years. Also requires colonoscopy if positive. |
| CT colonography | A CT-based virtual examination of the colon, usually every five years, with colonoscopy needed if a significant polyp is found. |
| Flexible sigmoidoscopy | Examines the lower colon and rectum, often combined with FIT. Less commonly used in the US than colonoscopy. |
| Staging investigations | After a cancer diagnosis: CT of the chest, abdomen, and pelvis, pelvic MRI for rectal cancer, carcinoembryonic antigen blood level, and tumour molecular and mismatch repair testing. |
Treatment overview
Treatment depends on stage, location, and molecular features, and is planned by a multidisciplinary team. The categories below describe modalities used; individual plans and dosing are set by the oncology team.
Endoscopic removal
Polyps and some very early cancers confined to the lining can be removed completely during colonoscopy without further surgery.
Surgery
Removal of the affected bowel segment with nearby lymph nodes is the mainstay for localised disease, performed openly, laparoscopically, or robotically.
Chemotherapy
Used after surgery to reduce recurrence risk in higher-stage disease, before surgery in some rectal cancers, and as ongoing treatment for advanced disease.
Radiation therapy
Used mainly in rectal cancer, often combined with chemotherapy before surgery to shrink the tumour and reduce local recurrence.
Targeted therapy
Drugs directed at specific tumour features such as EGFR or VEGF pathways, or BRAF and HER2 alterations, selected by molecular testing.
Immunotherapy
Checkpoint inhibitors are highly effective in the subset of tumours with mismatch repair deficiency or high microsatellite instability.
Supportive and survivorship care
Nutrition support, stoma care where relevant, management of treatment effects, and structured surveillance after treatment.
Lifestyle considerations
- Complete screening on schedule — this is the single most effective action available.
- Increase dietary fibre from vegetables, fruit, legumes, and whole grains.
- Limit red meat and minimise processed meat such as bacon, ham, and salami.
- Stay physically active most days; activity is consistently associated with lower risk.
- Maintain a healthy weight, particularly around the abdomen.
- Limit alcohol — risk rises with the amount consumed.
- Do not smoke, which raises risk of both polyps and cancer.
- Know your family history and share it with your clinician, since it can change your screening age and interval.
Prevention
- Begin screening at 45 if you are at average risk, and earlier if you have a family history or inflammatory bowel disease.
- Have polyps removed when found — this prevents the cancer rather than just catching it early.
- Eat a fibre-rich diet and limit processed meat.
- Stay physically active and maintain a healthy weight.
- Limit alcohol and avoid tobacco.
- Get evaluated promptly for rectal bleeding or a persistent change in bowel habit at any age.
- Ask about genetic counselling if colorectal, endometrial, or related cancers cluster in your family.
Warning signs and when to get help
Signs that need emergency care
If you believe you are experiencing a medical emergency, call emergency services immediately (911 in the United States).
- Heavy rectal bleeding, or bleeding with dizziness, fainting, or a racing pulse
- Severe abdominal pain with vomiting and inability to pass stool or wind — possible bowel obstruction
- A rigid, board-like abdomen with fever — possible perforation
- Black tarry stools with weakness or breathlessness
Signs that warrant a prompt appointment
These are not emergencies, but they are worth a call to your clinician rather than a wait-and-see.
- Any rectal bleeding, even if you assume it is hemorrhoids
- A change in bowel habit lasting more than three weeks
- Unintentional weight loss
- Persistent abdominal pain or a feeling of incomplete emptying
- Unexplained iron deficiency anemia
- A positive stool screening test — arrange colonoscopy promptly rather than repeating the stool test
Questions to ask a healthcare professional
Take these to your next appointment — or build an agenda with the Appointment Prep tool.
- At what age should I start screening given my family history?
- Which screening test is the best fit for me, and how often would I repeat it?
- If polyps were found, what type were they and when is my next colonoscopy due?
- Should I be referred for genetic counselling?
- What stage is my cancer, and what does that mean for treatment options?
- Has my tumour been tested for mismatch repair status and other molecular markers?
- What are the likely effects of treatment on my bowel function in the long term?
- What does follow-up surveillance look like after treatment?
Frequently asked questions
Why does colorectal cancer screening now start at 45?
Incidence in adults under 50 has been rising for several decades, and modelling showed that starting at 45 prevents more cancers and deaths than starting at 50. Both the USPSTF and the American Cancer Society now recommend average-risk screening from 45.
Which screening test is best?
The best test is the one you will actually do on schedule. Colonoscopy is the most thorough and allows polyp removal in the same session, while annual FIT or three-yearly stool DNA testing is less invasive. Any positive stool test must be followed by colonoscopy.
Is rectal bleeding always serious?
Most rectal bleeding comes from hemorrhoids or fissures, but it is not possible to be sure without evaluation, and assuming hemorrhoids is a common reason diagnosis is delayed. Any rectal bleeding should be reported to a clinician regardless of your age.
Does eating red meat cause colorectal cancer?
Processed meat is classified as carcinogenic to humans and red meat as probably carcinogenic, based on consistent associations. The increase in absolute risk for an individual is modest, and overall dietary pattern, weight, activity, alcohol, and screening matter more.
How long does it take a polyp to become cancer?
Typically ten to fifteen years for a conventional adenoma, though some serrated polyps and cancers in Lynch syndrome progress faster. That long window is precisely what makes screening so effective.
Do I still need screening if I feel completely well?
Yes. Early colorectal cancer and precancerous polyps usually cause no symptoms at all. Screening is designed for people who feel well; waiting for symptoms means finding disease at a later stage.
Sources
- American Cancer Society — Colorectal Cancer — Screening guidance, staging, and treatment overview
- USPSTF — Colorectal Cancer: Screening — Recommendation to screen adults aged 45-75
- NCI — Colorectal Cancer — NIH staging, treatment, and research information
- CDC — Colorectal Cancer — US screening data and prevention messaging
- MedlinePlus — Colorectal Cancer — Consumer summary and related tests
Health Captain links to primary public-health and clinical sources so you can read the original material yourself. See our sources policy.